Ensol Biosciences Inc. Logo

Ensol Biosciences Inc.

Develops AI-discovered peptide drugs for cancer, osteoarthritis, and Alzheimer's disease.

140610 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
대전광역시 유성구 테크노10로 51(탑립동), 대전광역시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Ensol Biosciences Inc. is a clinical-stage biopharmaceutical company developing innovative drugs for diseases with high unmet medical needs. The company specializes in creating PPI (Protein-Protein Interaction)-regulating short peptide drugs, utilizing a proprietary bio big data and AI platform for discovery and development. Its therapeutic approach focuses on local, non-blood injections to maximize efficacy, ensure high target specificity, and minimize systemic side effects due to a short half-life in the bloodstream. Ensol's clinical pipeline targets conditions such as osteoarthritis, degenerative disc disease, cancer, and Alzheimer's disease. Key candidates include E1K for osteoarthritis (preparing for Phase 3) and C1K, a combination cancer therapy (Phase 1).

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Ensol Biosciences Inc. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Ensol Biosciences Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Ensol Biosciences Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Optipharm.CO.,LTD Logo
Biotech for animal health and xenotransplantation using genetically engineered pig organs.
South Korea 153710
Organoid-based platforms for drug testing and regenerative therapeutics.
South Korea 476040
Oricon Inc. Logo
Provides entertainment industry data, music charts, web media, and marketing services.
Japan 4800
ORIENTBIO Inc. Logo
Provides animal models & technical services for preclinical R&D to pharma & research institutions.
South Korea 002630
Oryzon Genomics S.A. Logo
Develops epigenetic-based medicines for cancer and central nervous system disorders.
Spain ORY
OSCOTECInc. Logo
A clinical-stage drug discovery company developing innovative medicines for unmet needs.
South Korea 039200
OSE Immunotherapeutics Logo
Develops first-in-class immune therapies for oncology and inflammation, partnering for late-stage.
France OSE
Oxurion NV Logo
Acquires European pharmaceutical subcontractors to build an integrated healthcare services group.
Belgium OXUR
PA Co., Ltd Logo
Offers HR solutions like recruitment media, staffing, and childcare to revitalize local communities.
Japan 4766
PCI Biotech Holding Logo
Biopharma firm evaluating its future after discontinuing its core technology development.
Norway PCIB

Talk to a Data Expert

Have a question? We'll get back to you promptly.